Nu Skin announces closure of LifeGen acquisition

- Last updated on GMT

Related tags: Genetics, Nu skin

Nu Skin has closed the transaction to acquire LifeGen Technologies, a genomics company for $11.7m as it looks to extend and strengthen its line of anti-aging products.

Nu Skin announced a month ago that a deal was being worked on to acquire the Wisconsin-based firm along with its proprietary tissue bank and gene expression database, patents and other intellectual property related to anti-aging gene research.

“The global anti-aging market is expected to grow at a rapid rate in the coming years,” ​said Dr Joseph Chang, Nu Skin's chief scientific officer. “By bringing the proprietary LifeGen scientific assets and expertise in house, we believe we are in a unique position to develop a steady stream of our super-class of anti-aging products."

Nu Skin began its scientific collaboration with the genomics company two years ago with LifeGen's proprietary genetic science supporting its anti-aging products, including the company's most recent introduction of the ageLoc R2 nutritional supplement.

Related topics: Business & Financial

Related news

Show more

Follow us

Products

View more

Webinars